National Kidney Foundation Honors CareDx with Corporate Citizenship Award for its Commitment to the Transplant Community

April 6, 2023

National Kidney Foundation Honors CareDx with Corporate Citizenship Award for its Commitment to the Transplant Community

BRISBANE, Calif.–(BUSINESS WIRE)– CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that the National Kidney Foundation honored CareDx with a corporate citizenship award during its 41^st Annual Kidney Ball held on March 31, 2023, in Washington, D.C. Read the entire press release at CareDx.com.